References
Garbino J, Lew, D. P, Romand, J.-A, Hugonnet S, Auckenthaler R, Pittet D (2002) Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients. A randomized, double-blind, placebo-controlled trial in SDD-treated patients. Intensive Care Med 28:1708–1717
Saene HKF van, Silvestri L, Petros A, Viviani M, de la Cal MA, Zandstra DF (2003) Comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients." Intensive Care Med (http://dx.doi.org/10.1007/s00134-003-1770-7)
Slotman GJ, Burchard KW (1987) Ketoconazole prevents Candida sepsis in critically ill surgical patients. Arch Surg 122:147–151
Savino JA, Agarwal N, Wry P, Policastro A, Cerabona T, Austria L (1994) Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients. J Trauma 36:20–26
Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, Glauser MP, Calandra T (1999) Fluconazole prophylaxis of intra-abdominal candidiasis in high-risk surgical patients: a double-blind, placebo-controlled study. Crit Care Med 27:1066–1072
Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA (2001) Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 233:542–548
Philpott-Howard JN, Wade JJ, Mufti GJ, Brammer KW, Ehninger G, for the Multicentre Study Group (1993) Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. J Antimicrob Chemother 31:973–984
Lumbreras C, Cuervas-Mons V, Jara P, del Palacio A, Turrión VS, Barrios C, Moreno E, Noriega AR, Paya CV (1996) Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. J Infect Dis 174:583–588
De Pauw BE (1997) Practical modalities for prevention of fungal infections in cancer patients. Eur J Clin Microbiol Infect Dis 16:32–41
Rex JH, Sobel JD (2001) Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 32:1191–1200
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Calandra, T., Marchetti, O. Response to van Saene et al.'s comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients". Intensive Care Med 29, 1196 (2003). https://doi.org/10.1007/s00134-003-1842-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-003-1842-8